Gemmer Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-171
| Closed | -$70K | – | 1152 |
|
|
2022
Q1 | $70K | Buy |
171
+2
| +1% | +$783 | 0.01% | 211 |
|
|
2021
Q4 | $79K | Hold |
169
| – | – | 0.01% | 206 |
|
|
2021
Q3 | $72K | Hold |
169
| – | – | 0.01% | 193 |
|
|
2021
Q2 | $61K | Hold |
169
| – | – | 0.01% | 231 |
|
|
2021
Q1 | $48K | Hold |
169
| – | – | 0.01% | 256 |
|
|
2020
Q4 | $48K | Hold |
169
| – | – | 0.01% | 246 |
|
|
2020
Q3 | $46K | Hold |
169
| – | – | 0.01% | 222 |
|
|
2020
Q2 | $38K | Hold |
169
| – | – | 0.01% | 250 |
|
|
2020
Q1 | $26K | Hold |
169
| – | – | 0.01% | 281 |
|
|
2019
Q4 | $25K | Hold |
169
| – | – | 0.01% | 343 |
|
|
2019
Q3 | $24K | Hold |
169
| – | – | 0.01% | 348 |
|
|
2019
Q2 | $21K | Hold |
169
| – | – | 0.01% | 377 |
|
|
2019
Q1 | $19K | Hold |
169
| – | – | 0.01% | 441 |
|
|
2018
Q4 | $17K | Hold |
169
| – | – | 0.01% | 426 |
|
|
2018
Q3 | $21K | Hold |
169
| – | – | 0.01% | 397 |
|
|
2018
Q2 | $17K | Hold |
169
| – | – | 0.01% | 478 |
|
|
2018
Q1 | $15K | Hold |
169
| – | – | 0.01% | 523 |
|
|
2017
Q4 | $17K | Hold |
169
| – | – | 0.01% | 497 |
|
|
2017
Q3 | $16K | Hold |
169
| – | – | 0.01% | 485 |
|
|
2017
Q2 | $16K | Hold |
169
| – | – | 0.01% | 466 |
|
|
2017
Q1 | $14K | Hold |
169
| – | – | 0.01% | 515 |
|
|
2016
Q4 | $14K | Hold |
169
| – | – | 0.01% | 477 |
|
|
2016
Q3 | $13K | Hold |
169
| – | – | 0.01% | 492 |
|
|
2016
Q2 | $13K | Sell |
169
-83
| -33% | -$6.04K | 0.01% | 459 |
|
|
2016
Q1 | $17K | Hold |
252
| – | – | 0.01% | 364 |
|
|
2015
Q4 | $15K | Hold |
252
| – | – | 0.01% | 401 |
|
|
2015
Q3 | $14K | Hold |
252
| – | – | 0.01% | 432 |
|
|
2015
Q2 | $15K | Hold |
252
| – | – | 0.01% | 425 |
|
|
2015
Q1 | $15K | Hold |
252
| – | – | 0.01% | 452 |
|
|
2014
Q4 | $13K | Hold |
252
| – | – | 0.01% | 484 |
|
|
2014
Q3 | $11K | Hold |
252
| – | – | 0.01% | 531 |
|
|
2014
Q2 | $11K | Hold |
252
| – | – | 0.01% | 564 |
|
|
2014
Q1 | $11K | Buy |
+252
| New | +$11.9K | 0.01% | 552 |
|
Other funds holding WST
Gemmer Asset Management's WST Position: Q2 2022 in Review
Gemmer Asset Management sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 171 shares — an estimated $70K sold.
Gemmer Asset Management first reported a position in WST in Q1 2014 and held it in 33 quarters. The position peaked at $79K in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.
- Gemmer Asset Management reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 171 West Pharmaceutical shares in Q2 2022, an estimated $70K.
- Gemmer Asset Management first reported a position in West Pharmaceutical in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's West Pharmaceutical position peaked at $79K in Q4 2021.
- 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.